Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for anesthesia in short otorhinolaryngology surgery
ChiCTR2200067123Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zunyi Medical University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Second Affiliated Hospital of Zunyi Medical University. Primary endpoints: bispectral index (BIS), modified observers assessment alert/sedation (MOAA/S) and 3 more. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200067123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067123.